Primary squamous cell carcinoma of the parotid gland (pSCCP) has long been recognized as a separate entity and is included in the WHO classifications of salivary gland tumors. However, it is widely accepted among head and neck pathologists that pSCCP is exceptionally rare. Yet, there are many publications describing series of pSCCP and data from SEER and other cancer register databases indicate erroneously an increasing incidence of pSCCP. Importantly, pSCCP and metastatic (secondary) squamous cell carcinoma to the parotid gland (mSCCP) have nearly identical histological features, and the diagnosis of pSCCP should only be made after the exclusion of mSCCP. Moreover, all of the histological diagnostic criteria proposed to be in favor of pSCCP (such as, for example, dysplasia of ductal epithelium) can be encountered in unequivocal mSCCP, thereby representing secondary growth along preexistent ducts. Squamous cell differentiation has also been reported in rare genetically defined primary parotid carcinomas, either as unequivocal histological squamous features (e.g., NUT carcinoma, mucoepidermoid carcinoma), by immunohistochemistry (e.g., in NUT carcinoma, adamantinoma-like Ewing sarcoma, basal-type salivary duct carcinoma, mucoepidermoid carcinoma), or a combination of both. Another major issue in this context is that the International Classification of Diseases (ICD) coding system does not distinguish between primary or metastatic disease, resulting in a large number of patients with mSCCP being misclassified as pSCCP. Immunohistochemistry and new molecular biomarkers have significantly improved the accuracy of the diagnosis of many salivary gland neoplasms, but until recently there were no biomarkers that can accurately distinguish between mSCCP and pSCCP. However, recent genomic profiling studies have unequivocally demonstrated that almost all SCCP analyzed to date have an ultraviolet light (UV)-induced mutational signature typical of mSCCP of skin origin. Thus, mutational signature analysis can be a very useful tool in determining the cutaneous origin of these tumors. Additional molecular studies may shed new light on this old diagnostic and clinical problem. This review presents a critical view of head and neck experts on this topic.

Algarve Biomedical Center Research Institute Faro Portugal

Bioptic Laboratory Ltd Pilsen Czech Republic

Coordinator of the International Head and Neck Scientific Group Padua Italy

Department of Anatomical Pathology University of Calgary Calgary Alberta Canada

Department of Cellular Pathology Northern Lincolnshire and Goole NHS Foundation Trust Lincoln UK

Department of Otolaryngology Head and Neck Surgery Nottingham University Hospitals Queens Centre Campus Nottingham UK

Department of Pathology Hospital Clinic Barcelona Department of Basic Clinical Practice School of Medicine Universitat de Barcelona Barcelona Spain

Department of Pathology Kilimanjaro Christian Medical University College Moshi Tanzania

Department of Pathology Nijmegen Medical Centre Radboud University Nijmegen The Netherlands

Department of Pathology Sahlgrenska Center for Cancer Research University of Gothenburg Sahlgrenska University Hospital Gothenburg Sweden

Department of Pathology The University of Texas M D Anderson Cancer Center Houston TX USA

Department of Translational Research and New Technologies in Medicine and Surgery University of Pisa 56126 Pisa Italy

Faculty of Medicine and Biomedical Sciences University of Algarve Campus de Gambelas Ala Norte 8005 139 Faro Portugal

Head and Neck Pathology Consultations Woodlands Hills CA 91364 USA

Institute of Biomedicine Pathology University of Turku Turku Finland

Institute of Pathology Faculty of Medicine University of Ljubljana 1000 Ljubljana Slovenia

Institute of Pathology University Hospital Erlangen Friedrich Alexander University Erlangen Nürnberg Erlangen EMN Erlangen Germany

Sikl's Department of Pathology Faculty of Medicine in Pilsen Charles University Pilsen Czech Republic

Zobrazit více v PubMed

Locati LD, Ferrarotto R, Licitra L, Benazzo M, Preda L, Farina D et al (2023) Current management and future challenges in salivary gland cancer. Front Oncol 13:1254287. 10.3389/fonc.2023.126428710.3389/fonc.2023.1264287 PubMed DOI PMC

Zurek M, Fus L, Niemczyk K, Rzepakowsa A (2023) Salivary gland pathologies: evolution in classification and association with unique genetic alterations. Eur Arch Otorhinolaryngol 280:4739–4750. 10.1007/s00405-023-08110-w 10.1007/s00405-023-08110-w PubMed DOI PMC

Iyer J, Hariharan A, Cao UMN, Mai CTT, Wnag A, Khayambashi P, Nguyen BH, Safi L, Tran SD (2021) An overview on the histogenesis and morphogenesis of salivary gland neoplasms and evolving diagnostic approaches. Cancers 13:3910. 10.3390/cancers13153910 10.3390/cancers13153910 PubMed DOI PMC

Skalova A, Hyrcza MD, Leivo I (2022) Update from the 5th edition of the world health organization classification of head and neck tumors: salivary glands. Head Neck Pathol 16:40–53. 10.1007/xs12105-022-01420-1 10.1007/xs12105-022-01420-1 PubMed DOI PMC

Stodulski D, Majcwska H, Skalova A, Milaszewski B, Biernat W, Stankiewicz C (2016) Histological reclassification of parotid gland carcinomas: importance for clinicians. Eur Arch Otorhinolaryngol 273:3937–3942. 10.1007/s00405-016-4048-8 10.1007/s00405-016-4048-8 PubMed DOI PMC

Reerds STH, Uijen MJ, Van Engen-Van Grusven ACH, Marres HAM, van Herpen CML, Honings J (2022) Results of histopathological revisions of major salivary gland neoplasms in routine clinical practice. J Clin Pathol 76:374–378. 10.1136/jclinpath-2021-208072 10.1136/jclinpath-2021-208072 PubMed DOI

Godballe C, Schultz JH, Krogdahl A, Moller-Grontved A, Johansen J (2003) Parotid carcinoma: impact of clinical factors on prognosis in a histologically revised series. Laryngoscope 113:1411–1417. 10.1097/00005537-200308000-00028 10.1097/00005537-200308000-00028 PubMed DOI

Westergaard-Nielsen MW, Godballe C, Eriksen JG, Larsen SR, Kiss K et al (2021) Salivary gland carcinoma in Denmark: a national update and follow-up on incidence, histology, and outcome. Eur Arch Otorhinolaryngol 278:1179–1188. 10.1007/s00405-020-06205-2 10.1007/s00405-020-06205-2 PubMed DOI

Stanley MW, Bardales RH, Farmer CE, Frierson HF, Suhrland M, Powers CN, Rollins SD (1995) Primary and metastatic high-grade carcinomas of the salivary glands: a cytologic-histologic correlation study of twenty cases. Diagn Cytopathol 13:37–43. 10.1002/dc2840130109 10.1002/dc2840130109 PubMed DOI

Taxy JB (2001) Squamous carcinoma in a major salivary gland: a review of the diagnostic considerations. Arch Pathol Lab Med 125:740–745. 10.5858/2001-125-0740-SCIAMS 10.5858/2001-125-0740-SCIAMS PubMed DOI

Colombo E, Van Lierde C, Zlate A, Jensen A, Gatta G, Didone F, Licitra LF et al (2022) Salivary gland cancers in elderly patients: challenges and therapeutic strategies. Front Oncol 12:1032471. 10.3389/fonc.2022.1032471 10.3389/fonc.2022.1032471 PubMed DOI PMC

El-Naggar AK (2019) Management-based pathology assessment of salivary gland carcinoma. In: Locati LD (ed) Licitra L. Salivary Gland Cancer, From Diagn Tailored Treat. Springer Nature, pp 1–16

Seethala RR, Altemani AA, Ferris RL, Fonseca I, Gnepp DR, Ha P, Nagao T et al (2019) Data-set for the reporting of carcinoma of the major salivary glands. Arch Pathol Lab Med 143:578–586. 10.5858/arpa.2018-0422-SA 10.5858/arpa.2018-0422-SA PubMed DOI

Hellquist H, Skalova A (2014) Histopathology of the salivary glands (other carcinomas). Springer, Heidelberg, pp 375–427

Auclair PL, Ellis GL (1991) Primary squamous cell carcinoma. In: Ellis GL, Auclair PL, Gnepp DR (eds) Surgical Pathology of the Salivary Glands. Saunders WB, Philadelphia, pp 369–378

Foote FW, Frazell EL (1953) Tumors of the major salivary glands. Cancer 6:1065–1133. 10.1002/1097-0142(195311)6:6%3c1065::aid-cncr2820060602%3e3.0.co;2-0 10.1002/1097-0142(195311)6:6<1065::aid-cncr2820060602>3.0.co;2-0 PubMed DOI

Leader M, Jass JR (1985) In-situ neoplasia in squamous cell carcinoma of the parotid: a case report. Histopathology 9:325–329. 10.1111/j.1365-2559.1985.tb02450.x 10.1111/j.1365-2559.1985.tb02450.x PubMed DOI

Chiosea S, Hunt J, Nagao T, Westra WH (2017) Squamous cell carcinoma. In: El-Naggar A, Chan JKC, Grandis JR, Takata T, Slootweg PJ (eds) WHO Classification of Head and Neck Tumors. 4th edn. IARC, Lyon, p 182

Shemen LJ, Huvos AG, Spiro R (1987) Squamous cell carcinoma of salivary gland origin. Head Neck Surg 9:235–240. 10.1002/hed.2890090407 10.1002/hed.2890090407 PubMed DOI

Bradley PJ (2022) Parotid lymph nodes in primary malignant salivary lymph nodes. Curr Opin Otolaryngol Head Neck Surg 30:99–106. 10.1097/MOO.0000000000000772 10.1097/MOO.0000000000000772 PubMed DOI

O’Brien C (2003) The parotid gland as a metastatic basin for cutaneous cancer. Arch Otolaryngol Head Neck Surg 131:551–553. 10.1001/archotol.131.7.55110.1001/archotol.131.7.551 PubMed DOI

Pisani P, Krengli M, Ramponi A, Guglielmetti R, Pia F (1998) Metastasis to parotid gland from cancers of the upper airway and digestive tract. Br J Oral Maxillofac Surg 36:24–37. 10.1016/s0266-4356(98)90750-1 10.1016/s0266-4356(98)90750-1 PubMed DOI

Franzen AM, Gunzel T, Lieder A (2016) Parotid gland metastases of distant primary tumors: a diagnostic challenge. Auris Nasus Larynx 43:187–191. 10.1016/j.anl.2015.09.010 10.1016/j.anl.2015.09.010 PubMed DOI

Hurrell MJL, Low T-H, Ebrahimi A, Veness M, Ashford B, Porceddu S, Clark JR (2022) Evolution of head and neck cutaneous squamous cell carcinoma nodal staging – an Australian perspective. Cancers (Basel) 14:5101. 10.3390/cancers14205101 10.3390/cancers14205101 PubMed DOI PMC

Lee KJ, Soyer HP (2019) Cutaneous keratinocyte cancers of the head and neck: epidemiology, risk factors and clinical, dermoscopic and reflectance confocal microscopic features. Oral Oncol 98:109–117. 10.1016/j.oraloncology.2019.09.019 10.1016/j.oraloncology.2019.09.019 PubMed DOI

Khurana VG, Mentis DH, O’Brien CJ, Hurst TL, Stevens GN, Packham NA (1995) Parotid and neck metastases from cutaneous squamous cell carcinoma of the head and neck. Am J Surg 170:446–450. 10.1016/s0002-9610(99)80326-2 10.1016/s0002-9610(99)80326-2 PubMed DOI

Brougham NDLS, Dennett ER, Cameron R, Tan ST (2012) The incidence of metastasis from cutaneous squamous cell carcinoma and the impact of its risk factors. J Surg Oncol 106:811–815. 10.1002/jso.23155 10.1002/jso.23155 PubMed DOI

Mayer M, Thoelken R, Jering M, Markl B, Zenk J (2021) Metastases of cutaneous squamous cell carcinoma seem to be the most frequent malignancy in the parotid gland: a hospital-based study from a salivary gland center. Head Neck Pathol 15:843–851. 10.1007/s12105-021-01294-9 10.1007/s12105-021-01294-9 PubMed DOI PMC

Rao VM, Feng AL, Deschler DG, Kaufman HL, Lin DT, Miller D, Richmon JD et al (2023) Surgical factors affecting regionally metastatic cutaneous squamous cell carcinoma to the parotid gland. Head Neck 45:1080–1087. 10.1002/hed.27304 10.1002/hed.27304 PubMed DOI

Flukes S, Long S, Lohia S, Barker CA, Dunn LA, Cracchiolo J, Ganly I, Patel S, Cohen MA (2021) Metastatic cutaneous squamous cell carcinoma involving the parotid gland: experience outside the sun belt. Oto Open 5:1–8. 10.1177/2473974X2098472010.1177/2473974X20984720 PubMed DOI PMC

Stang A, Khil L, Kajuter H, Pandeya N, Schmults CD, Ruiz ES, Karla PS, Green AG (2019) Incidence and mortality for cutaneous squamous cell carcinoma: comparison across three continents. J Eur Acad Dermatol Venereol 33(Suppl 8):6–10. 10.1111/jdv.15967 10.1111/jdv.15967 PubMed DOI PMC

Leiter U, Keim U, Garbe C (2020) Epidemiology of skin cancer: update 2019. Adv Exp Med Biol 1268:123–139. 10.1007/978-3-030-46227-7_6 10.1007/978-3-030-46227-7_6 PubMed DOI

Desai N, Divatia MK, Jadhav A, Wagh A (2023) Aggressive cutaneous squamous cell carcinoma of the head and neck: a review. Curr Oncol 30:6634–6647. 10.3390/curroncol.30070487 10.3390/curroncol.30070487 PubMed DOI PMC

Czerwonka L, DeSantis RJ, Horowitz G, Hong M, Orsini M, Enepekides D, Goldstein DP, Dort J, Higgins K (2017) Staging cutaneous squamous cell carcinoma metastasis to the parotid gland. Laryngoscope 127:2063–2069. 10.1002/lary.26544 10.1002/lary.26544 PubMed DOI

Mooney CP, Clarke JR, Shannon K, Palme CE, Ebrahimi A, Gao K, Ch’ng S, Elliott M, Gupta R, Low TH (2021) The significance of regional metastasis location in head and neck cutaneous squamous cell carcinoma. Head Neck 43:2705–2711. 10.1002/hed.26744 10.1002/hed.26744 PubMed DOI

Del Signore AG, Megwalu UC (2017) The rising incidence of major salivary gland cancer in the United States. Ear Nose Throat J 96:E13–E15. 10.1177/014556131709600319 10.1177/014556131709600319 PubMed DOI

Chen MM, Roman SA, Sosa JA, Judson BL (2015) Prognostic factors for squamous cell carcinoma of the parotid gland: an analysis of 2104 patients. Head Neck 37:1–7. 10.1002/hed.23566 10.1002/hed.23566 PubMed DOI

Pfisterer MJ, Vazquez A, Mady LJ, Khan MN, Baredes S, Eloy JA (2014) Squamous cell carcinoma of the parotid gland: a population-based analysis of 2545 cases. Am J Otolaryngol Head Neck Surg 35:469–475. 10.1016/j.amjoto.2014.03.00310.1016/j.amjoto.2014.03.003 PubMed DOI

Nachtsheim L, Mayer M, Meyer ME, Oesterling F, Kajueter H, Arolt C, Quaas A, Klussmann JP, Wolber P (2023) Incidence and clinical outcome of primary carcinoma of the major salivary glands 10-year data from a population-based cancer register in Germany. J Can Res Clin Oncol 149:3811–3821. 10.1007/s00432-022-04278-610.1007/s00432-022-04278-6 PubMed DOI PMC

Oesterling F, Kajuter H, Nachtsheim L, Löning T, Strang A (2022) Letter: Parotid gland metastasis of cutaneous squamous cell carcinoma – a corroboration at population level. Head Neck Pathol 16:836–837. 10.1007/s12105-022-01443-8 10.1007/s12105-022-01443-8 PubMed DOI PMC

Girdler R, Odell E, Putnam G (2016) Epidemiology and management of major salivary gland cancer: National Cancer Registration and Analysis Service. Public Health England. Crown Copyright, PHE publications gateway number, p 2016314

Chernock RD, Lewis JS (2015) Approach to metastatic carcinoma of unknown primary in the head and neck: squamous cell carcinoma and beyond. Head Neck Pathol 9:6–15. 10.1007/s12105-015-0616-2 10.1007/s12105-015-0616-2 PubMed DOI PMC

Civantos FJ, Vermorken JB, Shah JP, Rinaldo A, Suarez C et al (2020) Metastatic squamous cell carcinoma to the cervical lymph nodes from an unknown primary cancer: management in the HPV era. Front Oncol 10:593164. 10.3389/fonc.2020.593164 10.3389/fonc.2020.593164 PubMed DOI PMC

Robinson L, van Heerden MB, Ker-Fox JG, Hunter KD (2021) Expression of mucins in salivary gland mucoepidermoid carcinoma. Head Neck Pathol 15:491–502. 10.1007/s12105-020-01226-z 10.1007/s12105-020-01226-z PubMed DOI PMC

Jo U, Song JS, Choi S-H, Nam SY, Kim SY, Cho K-J (2020) Primary squamous cell carcinoma of the salivary gland: immunohistochemical analysis and comparison with metastatic squamous cell carcinoma. J Pathol Transl Med 54:489–496. 10.4132/jptm.2020.07.19 10.4132/jptm.2020.07.19 PubMed DOI PMC

Bishop JA, Cown ML, Shum CH, Westra WH (2018) MAML2 Rearrangement in variant forms of mucoepidermoid carcinoma. Am J Surg Pathol 42:130–136. 10.1097/PAS.0000000000000932 10.1097/PAS.0000000000000932 PubMed DOI PMC

Skalova A, Stenman G, Simpson RHW, Hellquist H, Slouka D et al (2018) The role of molecular testing in the differential diagnosis of salivary gland carcinomas. Am J Surg Pathol 42:e11–e27. 10.1037/1097/PAS.00000000000980 10.1037/1097/PAS.00000000000980 PubMed DOI

Fehr A, Werenicz S, Trocchi P, Falk M, Fredrich RE, Stammler A et al (2021) Mucoepidermoid carcinoma of the salivary glands revisited with special reference to histologic grading and CTC1/3-MAML2 genotyping. Virchows Arch 479:975–985. 10.1007/s00428.021-03146-x 10.1007/s00428.021-03146-x PubMed DOI PMC

Nakaguro M, Tada Y, Faquin WC, Sadow PM, Wirth LJ (2020) Salivary duct carcinoma: updates in histology, cytology, molecular biology, and treatment. Cancer Cytopathol 126:693–703. 10.1002/cncy.2228810.1002/cncy.22288 PubMed DOI PMC

Chan JW, Yeh I, El-Sayed IH, Algazi AP, Glastonbury CM, Ha PK, Yom SS, van Zante A (2019) Ultraviolet light-related DNA damage mutation signature distinguishes cutaneous from mucosal or other origin for head and neck squamous cell carcinoma of unknown origin. Head Neck 41:E82–E85. 10.1002/hed.25613 10.1002/hed.25613 PubMed DOI

Fishbach S, Steinhardt G, Zhen CJ, Puranik R, Segal JP, Cipriani NA (2023) High rates of ultraviolet-signature mutations in squamous cell carcinomas of the parotid gland and prognostic implications. Head Neck Pathol 16:236–247. 10.1007/s12105-021-01349-x10.1007/s12105-021-01349-x PubMed DOI PMC

Gupta R, Strbenac D, Satgunaseelan L, Cheung VK-A, Narayanappa H, Ashford B, Mitchell J et al (2023) Comparing genomic landscapes of oral and cutaneous squamous cell carcinoma of the head and neck: quest for novel diagnostic markers. Mod Pathol 36:100190. 10.1016/j.modpat.2023.100190 10.1016/j.modpat.2023.100190 PubMed DOI

Dalin MG, Katabi N, Persson M, Lee K-W, Makarov V, Desrichard A, Walsh LA et al (2017) Multi-dimensional genomic analysis of myoepithelial carcinoma identifies prevalent oncogenic gene fusions. Nat Commun 8:1197–1210. 10.1038/s41467-017-01178-z 10.1038/s41467-017-01178-z PubMed DOI PMC

Agaimy A, Fonseca I, Martins C, Thway K, Barrette R, Harrington KJ, Hartmann A et al (2018) NUT carcinoma of the salivary glands: clinicopathologic and molecular analysis of 3 cases and a survey of NUT expression in salivary gland carcinomas. Am J Surg Pathol 42:877–884. 10.1097/PAS.0000000000001046 10.1097/PAS.0000000000001046 PubMed DOI PMC

Agaimy A, Stoehr R, Tögel L, Hartmann A, Cramer T (2021) YAP1-MAML2-rearranged poroid squamous cell carcinoma (squamoid porocarcinoma) presenting as a primary parotid tumor. Head Neck Pathol 15:361–367. 10.1007/s12105-020-01181-9 10.1007/s12105-020-01181-9 PubMed DOI PMC